FIFTH EXTENSION - GRANTED
granted
on 25 Sep 2024
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
90780500 filed on 17th Jun 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LYMQUI
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatolog Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90780500
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Sep 2024 | SOU EXTENSION 5 FILED |
| 25th Sep 2024 | SOU EXTENSION 5 GRANTED |
| 25th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
| 15th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 14th Mar 2024 | SOU EXTENSION 4 GRANTED |
| 14th Mar 2024 | SOU EXTENSION 4 FILED |
| 20th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Sep 2023 | SOU EXTENSION 3 GRANTED |